Search - tctmd.com

Displaying 241 - 260 of 796

Sort: Relevancy | Date

Experts Update Antithrombotic Advice in AF Patients Undergoing PCI

News Daily News

Experts Update Antithrombotic Advice in AF Patients Undergoing PCI

February 09, 2021

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

February 08, 2021

Large Meta-analysis Confirms Survival, Bleeding Benefits With Radial Access

News Daily News

Large Meta-analysis Confirms Survival, Bleeding Benefits With Radial Access

Michael O'Riordan

February 05, 2021

Post-TIA Stroke Risk Has Come Down Over Time, but Vigilance Still Needed

News Daily News

Post-TIA Stroke Risk Has Come Down Over Time, but Vigilance Still Needed

January 28, 2021

Based on Machine Learning, PRAISE Score Balances Risks in Post-ACS Care

News Daily News

Based on Machine Learning, PRAISE Score Balances Risks in Post-ACS Care

Yael L. Maxwell

January 26, 2021

Checklist for Same-Day Discharge PCI Stresses Buy-In, and a Plan

News Daily News

Checklist for Same-Day Discharge PCI Stresses Buy-In, and a Plan

January 07, 2021

Web-Like Structures in COVID-19 STEMI Clots May Offer New Drug Target

News Daily News

Web-Like Structures in COVID-19 STEMI Clots May Offer New Drug Target

January 04, 2021

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

December 23, 2020

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

December 22, 2020

Short-term Mortality Higher in Transfused TAVR Patients

News Daily News

Short-term Mortality Higher in Transfused TAVR Patients

December 10, 2020

Transradial Access Still Beats Transfemoral for STEMI in Updated Meta-analysis

News Daily News

Transradial Access Still Beats Transfemoral for STEMI in Updated Meta-analysis

November 25, 2020

Bleeds on Anticoagulants for A-Fib Can Unveil Occult Cancers

News Daily News

Bleeds on Anticoagulants for A-Fib Can Unveil Occult Cancers

November 06, 2020

H. Pylori in ACS: Could Tests and Treatment Beat Back the Bleeds?

News Daily News

H. Pylori in ACS: Could Tests and Treatment Beat Back the Bleeds?

November 05, 2020

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

News Daily News

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

October 29, 2020

More Teamwork, Coordination Could Boost CV Studies in COVID-19

News Daily News

More Teamwork, Coordination Could Boost CV Studies in COVID-19

October 28, 2020

New Review Urges Rethink of Cardiogenic Shock Care

News Daily News

New Review Urges Rethink of Cardiogenic Shock Care

October 27, 2020

Flash-Debate: Which Oral P2Y12 Inhibitor in ACS Treated With PCI? - Clopidogrel for Most!

Presentation TCT 2020

Clopidogrel for Most!

Presenter: John Bittl

October 15, 2020

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

Presentation TCT 2020

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

Presenter: Jose de la Torre Hernandez

October 14, 2020

TCT 058: Evaluation of Antithrombotic Strategies Before and After the First Month of Therapy: Landmark Analysis of the RE-DUAL PCI Trial

Presentation TCT 2020

TCT 058: Evaluation of Antithrombotic Strategies Before and After the First Month of Therapy: Landmark Analysis of the RE-DUAL PCI Trial

Presenter: Benjamin Peterson

October 14, 2020

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

News Daily News

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

October 09, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.